Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2003

01-03-2003

Expression of Sex Steroid Receptors and their Co-Factors in Normal and Malignant Breast Tissue: AIB1 is a Carcinoma-Specific Co-Activator

Authors: Gernot Hudelist, Klaus Czerwenka, Ernst Kubista, Erika Marton, Kerstin Pischinger, Christian F. Singer

Published in: Breast Cancer Research and Treatment | Issue 2/2003

Login to get access
Metadata
Title
Expression of Sex Steroid Receptors and their Co-Factors in Normal and Malignant Breast Tissue: AIB1 is a Carcinoma-Specific Co-Activator
Authors
Gernot Hudelist
Klaus Czerwenka
Ernst Kubista
Erika Marton
Kerstin Pischinger
Christian F. Singer
Publication date
01-03-2003
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 2/2003
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1022930710850

Other articles of this Issue 2/2003

Breast Cancer Research and Treatment 2/2003 Go to the issue

OriginalPaper

Estrogen-Induced Ets-1 Promotes Capillary Formation in an in vitro Tumor Angiogenesis Model

OriginalPaper

Exposures in Childhood, Adolescence and Early Adulthood and Breast Cancer Risk: a Systematic Review of the Literature

OriginalPaper

The Antiproliferative Effects of PPARγ Ligands in Normal Human Mammary Epithelial Cells

Instructions for Authors

Instructions for Authors

OriginalPaper

The Prognostic Value of the Human Kallikrein Gene 9 (KLK9) in Breast Cancer

OriginalPaper

Estradiol Enhances Osteolytic Lesions in Mice Inoculated with Human Estrogen Receptor-Negative MDA-231 Breast Cancer Cells in vivo
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits